Marcus Lind

University of Gothenburg

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Jing Wang

Dean and Professor

Florida State University

UNITED STATES

View details

Guillermo Umpierrez

Professor of Medicine

Emory University School of Medicine

UNITED STATES

View details

Michael A. Kohn

Professor Emeritus

University of California, San Francisco

UNITED STATES

View details

David Rodbard

Chief Scientific Officer

UNITED STATES

View details

Thomas Nyström

Karolinska Institutet

SWEDEN

View details

Anders Oldner

Karolinska University Hospital

SWEDEN

View details

Roman Hovorka

Professor of Metabolic Technology

University of Cambridge

UNITED KINGDOM

View details

Johnny Ludvigsson

Senior Professor

Linköping University

SWEDEN

View details

Christoph Nowak

Karolinska Institutet

SWEDEN

View details

Mihail Zilbermint

Johns Hopkins University School of Medicine

UNITED STATES

View details

Mikael Andersson Franko

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marcus Lind

Research Interests

Explore related searches

Contact this professor

Articles (14)

Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes

Trends in Survival After First Myocardial Infarction in People With Diabetes

Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes

The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial

Glycaemic control and sepsis risk in adults with type 1 diabetes

Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden

Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes.

Risk factors, mortality trends, and cardiovascular diseases in people with Type 1 diabetes and controls in Sweden: An observational cohort study

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Risk factors for nephropathy in persons with type 1 diabetes: a population-based study

Body mass index in adolescence, risk of type 2 diabetes and associated complications: A nationwide cohort study of men

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.

Collaborators (11)

Jing Wang

Guillermo Umpierrez

Michael A. Kohn

David Rodbard

Thomas Nyström

Anders Oldner

Roman Hovorka

Johnny Ludvigsson

Christoph Nowak

Mihail Zilbermint

Mikael Andersson Franko

Make your next move.